|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E,
Thomas M, Berdel WE, Serve H and Müller-Tidow C: MALAT-1, a novel
noncoding RNA, and thymosin beta4 predict metastasis and survival
in early-stage non-small cell lung cancer. Oncogene. 22:8031–8041.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1 - a paradigm for long noncoding RNA function in cancer. J
Mol Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thon JN, Devine MT, Jurak Begonja A,
Tibbitts J and Italiano JE Jr: High-content live-cell imaging assay
used to establish mechanism of trastuzumab emtansine
(T-DM1)-mediated inhibition of platelet production. Blood.
120:1975–1984. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y,
Xu Z and Han X: Cantharidin, a potent and selective PP2A inhibitor,
induces an oxidative stress-independent growth inhibition of
pancreatic cancer cells through G2/M cell-cycle arrest
and apoptosis. Cancer Sci. 101:1226–1233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stark GR and Taylor WR: Control of the
G2/M transition. Mol Biotechnol. 32:227–248. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ayyagari VN and Brard L: Bithionol
inhibits ovarian cancer cell growth in vitro - studies on
mechanism(s) of action. BMC Cancer. 14:612014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan JJ and Yang MH: The role of
epithelial-mesenchymal transition in pancreatic cancer. J
Gastrointest Oncol. 2:151–156. 2011.PubMed/NCBI
|
|
10
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell
LL, Polyak K, Brisken C, Yang J and Weinberg RA: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee CJ, Dosch J and Simeone DM: Pancreatic
cancer stem cells. J Clin Oncol. 26:2806–2812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rasheed ZA, Yang J, Wang Q, Kowalski J,
Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X,
Goggins M, Iacobuzio-Donahue C, Berman DM, Laheru D, Jimeno A,
Hidalgo M, Maitra A and Matsui W: Prognostic significance of
tumorigenic cells with mesenchymal features in pancreatic
adenocarcinoma. J Natl Cancer Inst. 102:340–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding
Q, Weng H, Shu YJ, Liu TY, Jiang L, Cao Y, Bao RF, Mu JS, Tan ZJ,
Tao F and Liu YB: MALAT1 promotes the proliferation and metastasis
of gallbladder cancer cells by activating the ERK/MAPK pathway.
Cancer Biol Ther. 15:806–814. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu JH, Chen G, Dang YW, Li CJ and Luo DZ:
Expression and prognostic significance of lncRNA MALAT1 in
pancreatic cancer tissues. Asian Pac J Cancer Prev. 15:2971–2977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Łukaszewicz M, Mroczko B and Szmitkowski
M: The role of metalloproteinases and their inhibitors in
pancreatic cancer. Postepy Hig Med Dosw (Online). 62:141–147.
2008.(In Polish).
|
|
20
|
Li Y, Kong D, Ahmad A, Bao B and Sarkar
FH: Pancreatic cancer stem cells: emerging target for designing
novel therapy. Cancer Lett. 338:94–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sarkar FH, Li Y, Wang Z and Kong D:
Pancreatic cancer stem cells and EMT in drug resistance and
metastasis. Minerva Chir. 64:489–500. 2009.PubMed/NCBI
|
|
22
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
